Biochemistry, Genetics and Molecular Biology
Proteomics
100%
Mass Spectrometry
59%
Proteome
43%
Fractionation
29%
Stromal Cell
29%
T Cell
28%
Precursor
27%
Cancer Cell
25%
Posttranslational Modification
24%
Halobacterium
24%
Glycosylation
23%
Gene Expression
22%
Halophilic Archaeon
19%
Epigenetics
19%
Ubiquitin
18%
Enzyme
18%
RNA
18%
Secretion (Process)
17%
Quantitative Proteomics
17%
Mesenchyme
17%
Kinase
16%
Phosphotransferase
16%
Enhancer Region
16%
Liquid Chromatography-Mass Spectrometry
15%
Matrix-Assisted Laser Desorption/Ionization
15%
Aspergillus nidulans
15%
RNA Polymerase II
15%
LNCaP
15%
Protease
15%
Shotgun Proteomics
15%
Deubiquitination
14%
Monoclonal Antibody
14%
Pseudomonas aeruginosa
13%
Tandem Mass Spectrometry
12%
Arginine
12%
Glycoprotein
11%
Type VI Secretion System
11%
Ion Current
11%
Polysaccharide
11%
Gene Expression Profiling
11%
Peptide Sequence
11%
Biomarker Discovery
10%
Ion Trap
10%
Electrospray Ionization
10%
Adenosine Diphosphate
10%
Promoter Region
10%
Homeostasis
10%
Downregulation
10%
Bioinformatics
9%
Secretome
9%
Keyphrases
Mass Spectrometry
60%
Proteomic Analysis
45%
Proteomics
38%
Type VI Secretion System
37%
Prostate
34%
Halobacteria
31%
Stromal Cells
25%
Urine Proteome
23%
Middle-down
21%
Bladder
21%
Pseudomonas Aeruginosa (P. aeruginosa)
20%
Type 6 Secretion
20%
Proteome
20%
Phosphorylation
19%
Shotgun Proteomics
18%
Gene Expression
18%
Acquisition Method
17%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
17%
T-cell Leukemia
17%
Urinary Bladder
17%
Data Independence
16%
Dynamic Range
16%
Human Prostate
16%
Immunohistochemistry
16%
Inflammation
16%
Leukemia
15%
REV-ERB
15%
Lipid Droplet Formation
15%
Microglia
15%
Tauopathy
15%
Male Mice
15%
Extreme Halophilic Archaea
15%
Aspergillus Nidulans
15%
Cyclic Dinucleotides
15%
Minimum Information
15%
In Situ Hybridization
15%
Deubiquitination
15%
Post-translational Modification
14%
Contact-dependent
14%
RNA Polymerase II (RNAPII)
14%
In Cancer
13%
Matrix-assisted Laser Desorption Ionization (MALDI)
13%
In-source Decay
13%
Fourier Transform Ion Cyclotron Resonance Mass Spectrometry (FT-ICR MS)
13%
Monoclonal Antibody
13%
Interbacterial Antagonism
13%
Prostate Cancer
13%
Data-dependent Acquisition
12%
Data-independent Acquisition
12%
Secretome
12%
